RecruitingNCT07458568

ViBandz Feasibility Study

ViBandz Feasibility Study in the Neurological Pediatric Population


Sponsor

Children's Mercy Hospital Kansas City

Enrollment

30 participants

Start Date

Apr 7, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This is a single site, mixed methods, feasibility study of the ViBandz device at a Midwest pediatric tertiary care hospital in a physical and occupational therapy clinic.


Eligibility

Min Age: 6 MonthsMax Age: 17 Years

Inclusion Criteria4

  • Children of ages 6 months to 17 years old
  • Neurologic conditions resulting in abnormal movement of at least one extremity
  • Appointment scheduled in CM PT/OT clinic that would include targeted focal vibration as a standard of care
  • English-speaking

Exclusion Criteria2

  • Wards of the state
  • Non-English speaking

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEViBandz

ViBandz is a device with straps and small vibrating motors that can be worn over muscles for stimulation and targeted vibration therapy. It was created to address the need for a hands-free vibrating device. There are different motor sizes and strap sizes for best fit with the patient. ViBandz also features a base station for powering the device and a key fob used to control the vibration therapy. Once all appropriate signatures have been obtained and all family/subject questions have been addressed, the subject will undergo their scheduled standard clinical Care (SOC) visit. The time with the ViBandz (10-15 minutes) will be less than full traditional targeted therapy (45 minutes) will help to control for subject fatigue as the vibration feeling stimulates muscles.: Video recordings via an iPad or similar device may be obtained during the subject's visit. These videos will allow for a closer inspection of subject interaction with the ViBandz.


Locations(1)

Children's Mercy Hospital

Kansas City, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07458568


Related Trials